Clinical Evaluation of Silk'n Glide for Face

Status Completed

Clinical Trial Summary

This is a clinical study to determine the efficacy and safety of the Glide, hair removal photo-depilation device, for removing facial hairs. During the first stage, the subjects will perform up to 6 face treatments, two weeks apart. The treatment's safety and efficiency will be evaluated at 4 weeks of after last treatment and at 12 weeks after last treatment.

Clinical Trial Description

Study efficacy assessment:

Comparison of hair counts before treatments to 4 and 12 weeks follow up visits.

Study safety assessment:

1. Reported errors and near errors using the device

2. Device malfunctions which relate to device safety

3. Device related adverse events

4. Non device related adverse events (secondary endpoint) ;

Study Design

Related Conditions & MeSH terms

Hirsutism

Clinical Trial Details

NCT number	NCT02103608
Study type	Interventional
Source	Home Skinovations Ltd.
Contact
Status	Completed
Phase	N/A
Start date	September 2013
Completion date	December 2014

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT00495443` - Enhanced Safety Aesthetic Laser System	N/A
Not yet recruiting	`NCT06003062` - Suppression of Upper Lip Hair Growth Using Novel Hemp Extract
Active, not recruiting	`NCT00145288` - Prospective Study of Patients With Hirsutism	Phase 2/Phase 3
Completed	`NCT00152048` - Evaluation of Eflornithine on Facial and Forearm Skin	Phase 4
Enrolling by invitation	`NCT01461694` - Facial Hair Reduction Using Intense Pulsed Light (IPL) & Alexandrite Laser	Phase 2/Phase 3
Not yet recruiting	`NCT00441948` - Enhanced Safety Laser Hair Removal System	N/A
Completed	`NCT03673995` - Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS	N/A
Recruiting	`NCT04979377` - Prevalence of Hyperandrogenism in Type 1 Diabetes
Completed	`NCT02494297` - DUS on the Prescribing Indications for CPA/EE in 5 European Countries
Completed	`NCT00960310` - Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed Conditions	Phase 1
Completed	`NCT02793557` - Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth	Phase 1/Phase 2
Completed	`NCT01817894` - Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism	Phase 4
Completed	`NCT01555190` - Combination Therapy With Myo-inositol and Folic Acid Versus Myo-inositol Alone	N/A
Completed	`NCT00143052` - Bone Status and Insulin Resistance in Hirsutism	N/A
Recruiting	`NCT01338519` - Database Study on Patients With PCOS	N/A
Recruiting	`NCT04292587` - Prevalence of Hirsutism in Turkey: Data of The Dermatoendocrinology Study Group
Completed	`NCT00959335` - Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions	Phase 1
Not yet recruiting	`NCT00371930` - Photodynamic Therapy for Permanent Hair Removal	Phase 1/Phase 2